Feedback activation of factor XI by thrombin does not occur in plasma.
In this study, we tested the hypothesis that factor XI (FXI) activation occurs in plasma following activation of the extrinsic pathway by thrombin-mediated feedback activation. We used two different assays: (i) a direct measurement of activated FXI by ELISA and (ii) a functional assay that follows the activation of the coagulation cascade in the presence or absence of a FXI inhibiting antibody by monitoring thrombin activity. We failed to detect any FXI activation or functional contribution to the activation of the coagulation cascade in platelet poor or platelet-rich plasma, when activation was initiated by thrombin or tissue factor. Additionally, we found that, in the absence of a contact system inhibitor during blood draw, contact activation of FXI can mistakenly appear as thrombin- or tissue-factor-dependent activation. Thus, activation of FXI by thrombin in solution or on the surface of activated platelets does not appear to play a significant role in a plasma environment. These results call for reevaluation of the physiological role of the contact activation system in blood coagulation.
Pedicord
Donna L
DL
Department of Chemical Enzymology, Bristol-Myers-Squibb Company, 311 Pennington-Rocky-Hill Road, Pennington, NJ 08534, USA.
Seiffert
Dietmar
D
Blat
Yuval
Y
D001792:Blood Platelets / Q000378:metabolism; D005172:Factor XI / Q000378:metabolism*; D005173:Factor XI Deficiency / Q000378:metabolism; D025461:Feedback, Physiological; D006801:Humans; D010949:Plasma / Q000378:metabolism; D010974:Platelet Aggregation; D013917:Thrombin / Q000378:metabolism*; D013925:Thromboplastin / Q000378:metabolism
D005172:Factor XI; D013925:Thromboplastin; D013917:Thrombin